CGMP/Finished Pharmaceuticals/Adulterated
Similar Posts
Cohance Lifesciences Limited – 8/12/2025
Cohance Lifesciences Limited – 8/12/2025. Country: India. Record Type: 483Matrixx Initiatives Inc. (Zicam), Scottdale, AZ 483 issued 5/28/2009, EIR signed 5/27/2005, and 483 issued 5/27/2005 (23 pages)
Matrixx Initiatives Inc. (Zicam), Scottdale, AZ 483 issued 5/28/2009, EIR signed 5/27/2005, and 483 issued 5/27/2005 (23 pages)DTF Sexual Chocolate may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use DTF Sexual Chocolate, a product promoted and sold for sexual enhancement on various websites, including shopsexology.com, and possibly in some retail stores.Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle
Foster City, Calif., September 20, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall of one lot of Veklury® (remdesivir) for Injection 100 mg/vial, to the consumer level. Gilead received a customer complaint and confirmed the presence of a glass particle inUnderstanding the Risks of Compounded Drugs
Compounded drugs are not FDA-approved. This means the agency does not verify their safety, effectiveness or quality before they are marketed. Learn more.Generic Drug User Fee Amendments
FDA is soliciting general comments on GDUFA II Program Fee: List of Abbreviated New Drug Application Sponsors and Application Numbers. The information gathered from public comments will assist FDA in accurately assessing FY 2018 GDUFA Program Fees in a timely manner.